Two antibiotic combinations for H. pylori stomach infection
Treatments studied
Part of Digestive system clinical trials.
This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 80 years old
- Confirmed H. pylori infection (detected by breath test, rapid test, biopsy, or stool sample)
- Never treated for H. pylori before, OR previous treatment failed and you need rescue therapy
- Able to take antibiotics daily for 14 days and attend follow-up visits
- No serious allergies to penicillin-based antibiotics or the study medications
- No severe liver or kidney disease, active bleeding, or other serious conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.
This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.
This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.
This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.
This trial tests two different ways to treat Helicobacter pylori (H. pylori), a bacteria that can cause stomach ulcers. One treatment combines three medicines (bismuth, amoxicillin, and vonoprazan), and the other uses four medicines (bismuth quadruple therapy). The goal is to see which works better.
This trial tests a simpler two-drug treatment for H. pylori infection, chosen based on a stool test that checks if the bacteria are resistant to clarithromycin. It may help people who have not been treated before avoid unnecessary antibiotics.
Hear when a new Helicobacter Pylori Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.